UNSPSC 51202421: Thymalfasin

Used in the treatment of B-cell acute lymphoblastic leukemia [ALL] treatment

UNSPSC 51202421 Thymalfasin is a Commodity code for a specific pharmaceutical product, but the single recent state and local opportunity tagged to it is a sole source procurement notice from the Mississippi State Department of Health for Yellow Fever Vaccine from Sanofi Pasteur, Inc., posted July 13, 2026, with objections due August 3, 2026 at 10:00 a.m. CST. The mismatch between the code's nominal scope (thymalfasin, an immunomodulating agent) and the actual solicitation (yellow fever vaccine) indicates that this code shows little relevant recent procurement activity aligned with its UNSPSC definition. State and local healthcare agencies do procure vaccines and biologics through sole source and competitive channels, but the single available record does not establish a pattern of activity under this specific Commodity code.

The Mississippi State Department of Health opportunity is structured as a notice of proposed sole source purchase rather than a standard competitive RFP, RFQ, or IFB. Interested vendors or their representatives may object to the sole source designation by submitting written notice with supporting documentation demonstrating that another vendor can supply the vaccine; submissions should be directed to Cynthia Brasher at the Mississippi State Department of Health Purchasing Department by hand delivery, regular mail, overnight delivery, or email at Cynthia.brasher@msdh.ms.gov. The notice does not specify quantity, contract term, estimated value, or pricing. If substantiated objections are received, the department will conduct an advertised competitive process; if the department determines only one source exists, it will appeal to the Public Procurement Review Board. Based on the limited and misaligned recent activity, this code does not currently signal a meaningful opportunity pipeline for vendors pursuing state and local pharmaceutical procurement.